By capturing 1,000 cell images per second, our Cell-CT platform does the hard work with its ability to correctly identify cell abnormality associated with cancer (sensitivity) while reducing false-positives (specificity). Detecting stage-one lung cancer is achievable with high sensitivity and specificity rates.
Check out our published studies for a more in-depth look at our sensitivity and specificity rates and the impact of these markers.
